{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:13:00Z","timestamp":1791979980417,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"PROSPECT","award":["W81XWH-07-1-0306"],"award-info":[{"award-number":["W81XWH-07-1-0306"]}]},{"name":"PS30 Cancer Center","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jtho.2017.10.033","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:43:59Z","timestamp":1512524639000},"page":"246-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Anne S.","family":"Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Vaporcyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waun Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.10.033_bib1","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","article-title":"Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results","volume":"57","author":"Rea","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2017.10.033_bib4","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"22","author":"Weder","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/5971","article-title":"Activating SRC mutation in a subset of advanced human colon cancers","volume":"21","author":"Irby","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2017.10.033_bib7","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jtho.2017.10.033_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/1-4020-7847-1_6","article-title":"Basis and importance of Src as a target in cancer","volume":"119","author":"Levin","year":"2004","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jtho.2017.10.033_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2017.10.033_bib10","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.90.16.7696","article-title":"The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells","volume":"90","author":"Twamley-Stein","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2017.10.033_bib11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/j.1460-2075.1993.tb05879.x","article-title":"Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases","volume":"12","author":"Mori","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.jtho.2017.10.033_bib12","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1074\/jbc.270.17.9840","article-title":"Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors","volume":"270","author":"Alonso","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtho.2017.10.033_bib13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1097-2765(00)80221-X","article-title":"Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability","volume":"4","author":"Eliceiri","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtho.2017.10.033_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/385595a0","article-title":"Three-dimensional structure of the tyrosine kinase c-Src","volume":"385","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2017.10.033_bib15","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1158\/1535-7163.MCT-07-0052","article-title":"Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion","volume":"6","author":"Tsao","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtho.2017.10.033_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2017.10.033_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<151::AID-PATH425>3.0.CO;2-E","article-title":"Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in\u00a0vitro and in\u00a0vivo","volume":"178","author":"Langerak","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jtho.2017.10.033_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s004280050388","article-title":"Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma","volume":"435","author":"Konig","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2017.10.033_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jtho.2017.10.033_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0","article-title":"Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression","volume":"189","author":"Kumar-Singh","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jtho.2017.10.033_bib21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jtho.2017.10.033_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jtho.2017.10.033_bib23","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1158\/1078-0432.CCR-05-0757","article-title":"Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells","volume":"11","author":"Johnson","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.033_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-895X(25)09719-6","article-title":"Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme","volume":"46","author":"Dorai","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jtho.2017.10.033_bib25","first-page":"24","article-title":"Cytokine regulation of mesothelial cell proliferation in\u00a0vitro and in\u00a0vivo","volume":"72","author":"Mutsaers","year":"1997","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jtho.2017.10.033_bib26","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.athoracsur.2005.06.014","article-title":"Extended surgical staging for potentially resectable malignant pleural mesothelioma","volume":"80","author":"Rice","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2017.10.033_bib27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2017.10.033_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2353\/ajpath.2007.060706","article-title":"SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines","volume":"170","author":"Zhang","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtho.2017.10.033_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/1078-0432.CCR-09-0650","article-title":"Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions","volume":"16","author":"Behrens","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.033_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2353\/ajpath.2006.050570","article-title":"Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model","volume":"168","author":"Trevino","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtho.2017.10.033_bib32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2007.04.076","article-title":"Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"84","author":"Rice","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2017.10.033_bib33","series-title":"Statistical Methods for the\u00a0Analysis of Biomedical Data","author":"Woolson","year":"2002"},{"key":"10.1016\/j.jtho.2017.10.033_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimator from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jtho.2017.10.033_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0Royal Stat Society Ser B"},{"key":"10.1016\/j.jtho.2017.10.033_bib36","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/bioinformatics\/btm283","article-title":"Non-parametric quantification of protein lysate arrays","volume":"23","author":"Hu","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jtho.2017.10.033_bib37","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/1078-0432.CCR-09-0767","article-title":"Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer","volume":"15","author":"Byers","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2017.10.033_bib38","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/JTO.0b013e3181f2a266","article-title":"Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence","volume":"5","author":"Nanjundan","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.94.3.861","article-title":"Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways","volume":"94","author":"Arbiser","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2017.10.033_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00280-008-0699-5","article-title":"Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor","volume":"62","author":"Luo","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtho.2017.10.033_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3816\/CLC.2009.n.005","article-title":"Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma","volume":"10","author":"Tsao","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2017.10.033_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.semtcvs.2014.12.005","article-title":"Current readings: window-of-opportunity trials for thoracic malignancies","volume":"26","author":"Tsao","year":"2014","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2017.10.033_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jtho.2017.10.033_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.matbio.2009.10.004","article-title":"Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells","volume":"29","author":"Patel","year":"2010","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jtho.2017.10.033_bib46","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jtho.2017.05.021","article-title":"Phase I trial of cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905)","volume":"12","author":"Tsao","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2017.10.033_bib47","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608641733068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608641733068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:05:40Z","timestamp":1751083540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155608641733068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S155608641733068X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.10.033","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}